Using ruminally protected and nonprotected active dried yeast as alternatives to antibiotics in finishing beef steers: growth performance, carcass traits, blood metabolites, and fecal Escherichia coli.

The objective of this study was to evaluate the effects of supplementing the diet of finishing beef steers with active dried yeast (ADY) in ruminally protected and nonprotected forms on growth performance, carcass traits, and immune response. Seventy-five individually-fed Angus steers (initial body weight (BW) ± SD, 448 ± 8.4 kg) were assigned to a randomized complete design with 5 treatments: 1) control (no monensin, tylosin, or ADY), 2) antibiotics (ANT, 330 mg monensin + 110 mg tylosin·steer-1d-1), 3) ADY (1.5 g·steer-1d-1), 4) encapsulated ADY (EDY; 3 g·steer-1d-1), and 5) a mixture of ADY and EDY (MDY; 1.5 g ADY + 3 g EDY·steer-1d-1). Active dried yeast with 1.7 × 1010 cfu/g was encapsulated in equal amounts of ADY and capsule materials (stearic acid and palm oil). Steers were fed a total mixed ration containing 10% barley silage and 90% barley-based concentrate mix (dry matter [DM] basis). The ANT, ADY, and EDY were top-dressed daily to the diet at feeding. Intake of DM, final BW, averaged daily gain (ADG), and gain-to-feed ratio (G:F) were unaffected by ADY or EDY. Carcass traits including hot carcass weight (HCW), dressing percentage, marbling score and quality grade did not differ among treatments, although fewer severely abscessed livers were observed (P < 0.05) with ADY and MDY compared with the other treatments. Plasma urea N tended (P < 0.10) to be greater in steers fed ANT, ADY, or EDY on day 56 and 112, while glucose remained stable in all treatments except greater (P < 0.02) plasma glucose occurred in steers fed MDY on day 112. Serum nonestrified fatty acid (NEFA) was unaffected by ADY or EDY, but it was greater (P < 0.03) in steers fed ANT compared with control. Plasma haptoglobin (Hp) and serum amyloid A (SAA) were affected by yeast supplementation on day 112, with greater (P < 0. 01) Hp in steers fed ADY, EDY, or MDY and lesser (P < 0.01) SAA in steers fed EDY and MDY than control. Lipopolysaccharide binding protein concentrations were greater (P < 0.01) in steers fed EDY and MDY on day 56. Supplementing with ADY (protected or nonprotected) or ANT had no effect on fecal IgA contents on day 56 and 112. Steers fed yeast (EDY or MDY) tended (P < 0.10) to have fewer fecal Escherichia coli counts than the control and ANT on day 56 and 112. These results indicate that feeding ADY to feedlot cattle may exhibit antipathogenic activity that conferred health and food safety beneficial effects including reduced liver abscess and potentially pathogen excretion, thus yeast may be an alternative to in-feed antibiotics in natural beef cattle production systems.